162 related articles for article (PubMed ID: 33032865)
21. Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial.
Puijk RS; Ruarus AH; Vroomen LGPH; van Tilborg AAJM; Scheffer HJ; Nielsen K; de Jong MC; de Vries JJJ; Zonderhuis BM; Eker HH; Kazemier G; Verheul H; van der Meijs BB; van Dam L; Sorgedrager N; Coupé VMH; van den Tol PMP; Meijerink MR;
BMC Cancer; 2018 Aug; 18(1):821. PubMed ID: 30111304
[TBL] [Abstract][Full Text] [Related]
22. Stereotactic radiofrequency ablation of primary liver tumors in the caudate lobe.
Schullian P; Laimer G; Putzer D; Effenberger M; Bale R
HPB (Oxford); 2020 Mar; 22(3):470-478. PubMed ID: 31591012
[TBL] [Abstract][Full Text] [Related]
23. Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection.
Dupré A; Jones RP; Diaz-Nieto R; Fenwick SW; Poston GJ; Malik HZ
Eur J Surg Oncol; 2017 Oct; 43(10):1901-1907. PubMed ID: 28888801
[TBL] [Abstract][Full Text] [Related]
24. Comparative analysis of radiofrequency ablation and resection for colorectal liver metastases in caudate lobe: a retrospective study.
Li P; Kong L; Wang Y; Lv X; Wang J; Gao H
Acta Chir Belg; 2020 Oct; 120(5):321-328. PubMed ID: 31187689
[No Abstract] [Full Text] [Related]
25. Systematic review and meta-analysis of local ablative therapies for resectable colorectal liver metastases.
Di Martino M; Rompianesi G; Mora-Guzmán I; Martín-Pérez E; Montalti R; Troisi RI
Eur J Surg Oncol; 2020 May; 46(5):772-781. PubMed ID: 31862133
[TBL] [Abstract][Full Text] [Related]
26. Microwave ablation with or without resection for colorectal liver metastases.
Stättner S; Jones RP; Yip VS; Buchanan K; Poston GJ; Malik HZ; Fenwick SW
Eur J Surg Oncol; 2013 Aug; 39(8):844-9. PubMed ID: 23769976
[TBL] [Abstract][Full Text] [Related]
27. Clinical Outcomes and Predictors in Patients With Unresectable Colorectal Cancer Liver Metastases Following Salvage Percutaneous Radiofrequency Ablation: A Single Center Preliminary Experience.
Wang Y; Zhang GY; Xu LC; He XH; Huang HZ; Li GD; Wang YH; Wang GZ; Li WT
Technol Cancer Res Treat; 2020; 19():1533033820963662. PubMed ID: 33034276
[TBL] [Abstract][Full Text] [Related]
28. Radiofrequency ablation vs. hepatic resection for resectable colorectal liver metastases.
He N; Jin QN; Wang D; Yang YM; Liu YL; Wang GB; Tao KX
J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):514-518. PubMed ID: 27465325
[TBL] [Abstract][Full Text] [Related]
29. Comparison of radiofrequency ablation and resection for hepatic metastasis from colorectal cancer.
Lee KH; Kim HO; Yoo CH; Son BH; Park YL; Cho YK; Kim H; Han WK
Korean J Gastroenterol; 2012 Mar; 59(3):218-23. PubMed ID: 22460570
[TBL] [Abstract][Full Text] [Related]
30. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery.
Park IJ; Kim HC; Yu CS; Kim PN; Won HJ; Kim JC
Ann Surg Oncol; 2008 Jan; 15(1):227-32. PubMed ID: 17882491
[TBL] [Abstract][Full Text] [Related]
31. Stereotactic Radiofrequency Ablation of Liver Tumors in Octogenarians.
Schullian P; Putzer D; Silva MA; Laimer G; Kolbitsch C; Bale R
Front Oncol; 2019; 9():929. PubMed ID: 31608232
[No Abstract] [Full Text] [Related]
32. Technical efficacy and local recurrence after stereotactic radiofrequency ablation of 2653 liver tumors: a 15-year single-center experience with evaluation of prognostic factors.
Schullian P; Laimer G; Johnston E; Putzer D; Eberle G; Scharll Y; Widmann G; Kolbitsch C; Bale R
Int J Hyperthermia; 2022; 39(1):421-430. PubMed ID: 35227136
[TBL] [Abstract][Full Text] [Related]
33. Quality of life analysis after stereotactic radiofrequency ablation of liver tumors.
Schullian P; Gertl A; Laimer G; Putzer D; Siebert U; Levy E; Bale R
Sci Rep; 2020 Jul; 10(1):12809. PubMed ID: 32732877
[TBL] [Abstract][Full Text] [Related]
34. Surgical and oncologic outcomes following repeat hepatic resection of colorectal liver metastasis: Who benefits?
Wong LH; Sutton TL; Walker BS; Lopez CD; Kardosh A; Eil RL; Chen EY; Billingsley KG; Mayo SC
Am J Surg; 2021 Jun; 221(6):1114-1118. PubMed ID: 33722380
[TBL] [Abstract][Full Text] [Related]
35. Repeat hepatic resection in patients with colorectal liver metastases.
Lee H; Choi SH; Cho YB; Yun SH; Kim HC; Lee WY; Heo JS; Choi DW; Jung KU; Chun HK
World J Gastroenterol; 2015 Feb; 21(7):2124-30. PubMed ID: 25717247
[TBL] [Abstract][Full Text] [Related]
36. Stereotactic radiofrequency ablation (SRFA) of liver lesions: technique effectiveness, safety, and interoperator performance.
Widmann G; Schullian P; Haidu M; Bale R
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):570-80. PubMed ID: 21671150
[TBL] [Abstract][Full Text] [Related]
37. Resectable recurrent colorectal liver metastasis: can radiofrequency ablation replace repeated metastasectomy?
Mao R; Zhao JJ; Bi XY; Zhang YF; Han Y; Li ZY; Zhao H; Cai JQ
ANZ J Surg; 2019 Jul; 89(7-8):908-913. PubMed ID: 31090189
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcomes of hepatic resection and radiofrequency ablation in patients with solitary colorectal liver metastasis.
Lee WS; Yun SH; Chun HK; Lee WY; Kim SJ; Choi SH; Heo JS; Joh JW; Choi D; Kim SH; Rhim H; Lim HK
J Clin Gastroenterol; 2008 Sep; 42(8):945-9. PubMed ID: 18438208
[TBL] [Abstract][Full Text] [Related]
39. CT-guided percutaneous radiofrequency ablation for lung metastases from colorectal cancer.
Hiyoshi Y; Miyamoto Y; Kiyozumi Y; Sawayama H; Eto K; Nagai Y; Iwatsuki M; Iwagami S; Baba Y; Yoshida N; Kawanaka K; Yamashita Y; Baba H
Int J Clin Oncol; 2019 Mar; 24(3):288-295. PubMed ID: 30328530
[TBL] [Abstract][Full Text] [Related]
40. Propensity score matching demonstrates similar results for radiofrequency ablation compared to surgical resection in colorectal liver metastases.
van de Geest TW; van Amerongen MJ; Nierop PMH; Höppener DJ; Grünhagen DJ; Moelker A; Fütterer JJ; Verhoef C; de Wilt JHW
Eur J Surg Oncol; 2022 Jun; 48(6):1368-1374. PubMed ID: 35078702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
